Thomas Flaten
Stock Analyst at Lake Street
(0.59)
# 2208
Out of 5,259 analysts
43
Total ratings
42.31%
Success rate
0.60%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OCX OncoCyte | Initiates Coverage On: Buy | 5 | 3.4 | 47.06% | 5 | Mar 28, 2025 | |
OPTN OptiNose | Downgrades: Hold | 17 9 | 9.27 | -2.91% | 5 | Mar 20, 2025 | |
CKPT Checkpoint Therapeut... | Downgrades: Hold | 7 5 | n/a | n/a | 5 | Mar 10, 2025 | |
AQST Aquestive Therapeuti... | Maintains: Buy | 10 8 | 2.88 | 177.78% | 2 | Mar 7, 2025 | |
EVAX Evaxion Biotech | Maintains: Buy | 35 6 | 1.64 | 265.85% | 2 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 9 | 3.85 | 133.77% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 34 40 | 20.67 | 93.52% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 7.47 | 20.48% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.62 | 383.87% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 2.37 | 364.14% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 24.93 | 0.28% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 3.27 | 43936.7% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 4.02 | 99% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |